APO Research
Talk to an analyst

APO RESEARCH · REPORT

Remdesivir

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Remdesivir Market Outlook and Growth Opportunities 2026

2 January 2026191 pages

Choose your research edition.

Industry ResearchRemdesivir Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Remdesivir Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Remdesivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Remdesivir Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Remdesivir Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Remdesivir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Remdesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Remdesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Remdesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Remdesivir market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Remdesivir market include Kelun Pharma, Hunan Warrant Pharmaceutical, Hainan Haiyao, Bright Gene and Gilead Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Remdesivir market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Remdesivir and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Remdesivir sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Remdesivir market size, projected growth trends, production technologies, key applications, and end-use industries.

Remdesivir Segment by Company

Kelun Pharma

Hunan Warrant Pharmaceutical

Hainan Haiyao

Bright Gene

Gilead Sciences

Remdesivir Segment by Type

10 mM*1 mL in DMSO

100mg

10mg

50mg

5mg

Remdesivir Segment by Application

Drug Store

Hospital

Clinics

Others

Remdesivir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Remdesivir status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Remdesivir market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Remdesivir significant trends, drivers, influence factors in global and regions.

6. To analyze Remdesivir competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Remdesivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Remdesivir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Remdesivir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Remdesivir market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Remdesivir industry.

Chapter 3: Detailed analysis of Remdesivir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Remdesivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Remdesivir in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Remdesivir Industry Trends Table 2. Remdesivir Industry Drivers Table 3. Remdesivir Industry Opportunities and Challenges Table 4. Remdesivir Industry Restraints Table 5. Global Remdesivir Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Remdesivir Revenue Share by Company (2021-2026) Table 7. Global Remdesivir Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Remdesivir Sales Volume Share by Company (2021-2026) Table 9. Global Remdesivir Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Remdesivir Company Ranking, (2024-2026) & (USD Million) Table 11. Global Remdesivir Key Company Manufacturing Base & Headquarters Table 12. Global Remdesivir Company, Product Type & Application Table 13. Global Remdesivir Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Remdesivir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10 mM*1 mL in DMSO Table 18. Significant Companies of 100mg Table 19. Significant Companies of 10mg Table 20. Significant Companies of 50mg Table 21. Significant Companies of 5mg Table 22. Global Remdesivir Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Remdesivir Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Remdesivir Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Remdesivir Sales Volume Share by Type (2021-2026) Table 26. Global Remdesivir Sales Volume Share by Type (2027-2032) Table 27. Global Remdesivir Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Remdesivir Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Remdesivir Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Remdesivir Sales Value Share by Type (2021-2026) Table 31. Global Remdesivir Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Drug Store Table 33. Significant Companies of Hospital Table 34. Significant Companies of Clinics Table 35. Significant Companies of Others Table 36. Global Remdesivir Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Remdesivir Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Remdesivir Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Remdesivir Sales Volume Share by Application (2021-2026) Table 40. Global Remdesivir Sales Volume Share by Application (2027-2032) Table 41. Global Remdesivir Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Remdesivir Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Remdesivir Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Remdesivir Sales Value Share by Application (2021-2026) Table 45. Global Remdesivir Sales Value Share by Application (2027-2032) Table 46. Global Remdesivir Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Remdesivir Sales by Region (2021-2026) & (K Units) Table 48. Global Remdesivir Sales Market Share by Region (2021-2026) Table 49. Global Remdesivir Sales by Region (2027-2032) & (K Units) Table 50. Global Remdesivir Sales Market Share by Region (2027-2032) Table 51. Global Remdesivir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Remdesivir Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Remdesivir Sales Value Share by Region (2021-2026) Table 54. Global Remdesivir Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Remdesivir Sales Value Share by Region (2027-2032) Table 56. Global Remdesivir Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Remdesivir Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Remdesivir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Remdesivir Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Remdesivir Sales by Country (2021-2026) & (K Units) Table 61. Global Remdesivir Sales Market Share by Country (2021-2026) Table 62. Global Remdesivir Sales by Country (2027-2032) & (K Units) Table 63. Global Remdesivir Sales Market Share by Country (2027-2032) Table 64. Global Remdesivir Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Remdesivir Sales Value Market Share by Country (2021-2026) Table 66. Global Remdesivir Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Remdesivir Sales Value Market Share by Country (2027-2032) Table 68. Kelun Pharma Company Information Table 69. Kelun Pharma Business Overview Table 70. Kelun Pharma Remdesivir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Kelun Pharma Remdesivir Product Portfolio Table 72. Kelun Pharma Recent Development Table 73. Hunan Warrant Pharmaceutical Company Information Table 74. Hunan Warrant Pharmaceutical Business Overview Table 75. Hunan Warrant Pharmaceutical Remdesivir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hunan Warrant Pharmaceutical Remdesivir Product Portfolio Table 77. Hunan Warrant Pharmaceutical Recent Development Table 78. Hainan Haiyao Company Information Table 79. Hainan Haiyao Business Overview Table 80. Hainan Haiyao Remdesivir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hainan Haiyao Remdesivir Product Portfolio Table 82. Hainan Haiyao Recent Development Table 83. Bright Gene Company Information Table 84. Bright Gene Business Overview Table 85. Bright Gene Remdesivir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Bright Gene Remdesivir Product Portfolio Table 87. Bright Gene Recent Development Table 88. Gilead Sciences Company Information Table 89. Gilead Sciences Business Overview Table 90. Gilead Sciences Remdesivir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Gilead Sciences Remdesivir Product Portfolio Table 92. Gilead Sciences Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Remdesivir Distributors List Table 96. Remdesivir Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Remdesivir Product Image Figure 2. Global Remdesivir Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Remdesivir Sales Value (2021-2032) & (US$ Million) Figure 4. Global Remdesivir Sales (2021-2032) & (K Units) Figure 5. Global Remdesivir Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Remdesivir Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10 mM*1 mL in DMSO Image Figure 10. 100mg Image Figure 11. 10mg Image Figure 12. 50mg Image Figure 13. 5mg Image Figure 14. Global Remdesivir Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Remdesivir Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Remdesivir Sales Volume Share by Type (2021-2032) Figure 17. Global Remdesivir Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Remdesivir Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Remdesivir Sales Value Share by Type (2021-2032) Figure 20. Drug Store Image Figure 21. Hospital Image Figure 22. Clinics Image Figure 23. Others Image Figure 24. Global Remdesivir Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Remdesivir Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Remdesivir Sales Volume Share by Application (2021-2032) Figure 27. Global Remdesivir Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Remdesivir Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Remdesivir Sales Value Share by Application (2021-2032) Figure 30. Global Remdesivir Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Remdesivir Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Remdesivir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Remdesivir Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Remdesivir Sales Value (2021-2032) & (US$ Million) Figure 35. North America Remdesivir Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Remdesivir Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Remdesivir Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Remdesivir Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Remdesivir Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Remdesivir Sales Value (2021-2032) & (US$ Million) Figure 41. South America Remdesivir Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Remdesivir Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Remdesivir Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Remdesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Remdesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Remdesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Remdesivir Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Remdesivir Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • 10 mM*1 mL in DMSO
  • 100mg
  • 10mg
  • 50mg
  • 5mg
Applications
  • Drug Store
  • Hospital
  • Clinics
  • Others
Companies covered
  • Kelun Pharma
  • Hunan Warrant Pharmaceutical
  • Hainan Haiyao
  • Bright Gene
  • Gilead Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Remdesivir Sales Value (2021-2032)
  4. 1.2.2 Global Remdesivir Sales Volume (2021-2032)
  5. 1.2.3 Global Remdesivir Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Remdesivir Market Dynamics
  1. 2.1 Remdesivir Industry Trends
  2. 2.2 Remdesivir Industry Drivers
  3. 2.3 Remdesivir Industry Opportunities and Challenges
  4. 2.4 Remdesivir Industry Restraints
3 Remdesivir Market by Company
  1. 3.1 Global Remdesivir Company Revenue Ranking in 2025
  2. 3.2 Global Remdesivir Revenue by Company (2021-2026)
  3. 3.3 Global Remdesivir Sales Volume by Company (2021-2026)
  4. 3.4 Global Remdesivir Average Price by Company (2021-2026)
  5. 3.5 Global Remdesivir Company Ranking (2024-2026)
  6. 3.6 Global Remdesivir Company Manufacturing Base and Headquarters
  7. 3.7 Global Remdesivir Company Product Type and Application
  8. 3.8 Global Remdesivir Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Remdesivir Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Remdesivir Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Remdesivir Market by Type
  1. 4.1 Remdesivir Type Introduction
  2. 4.1.1 10 mM*1 mL in DMSO
  3. 4.1.2 100mg
  4. 4.1.3 10mg
  5. 4.1.4 50mg
  6. 4.1.5 5mg
  7. 4.2 Global Remdesivir Sales Volume by Type
  8. 4.2.1 Global Remdesivir Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Remdesivir Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Remdesivir Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Remdesivir Sales Value by Type
  12. 4.3.1 Global Remdesivir Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Remdesivir Sales Value by Type (2021-2032)
  14. 4.3.3 Global Remdesivir Sales Value Share by Type (2021-2032)
5 Remdesivir Market by Application
  1. 5.1 Remdesivir Application Introduction
  2. 5.1.1 Drug Store
  3. 5.1.2 Hospital
  4. 5.1.3 Clinics
  5. 5.1.4 Others
  6. 5.2 Global Remdesivir Sales Volume by Application
  7. 5.2.1 Global Remdesivir Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Remdesivir Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Remdesivir Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Remdesivir Sales Value by Application
  11. 5.3.1 Global Remdesivir Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Remdesivir Sales Value by Application (2021-2032)
  13. 5.3.3 Global Remdesivir Sales Value Share by Application (2021-2032)
6 Remdesivir Regional Sales and Value Analysis
  1. 6.1 Global Remdesivir Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Remdesivir Sales by Region (2021-2032)
  3. 6.2.1 Global Remdesivir Sales by Region: 2021-2026
  4. 6.2.2 Global Remdesivir Sales by Region (2027-2032)
  5. 6.3 Global Remdesivir Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Remdesivir Sales Value by Region (2021-2032)
  7. 6.4.1 Global Remdesivir Sales Value by Region: 2021-2026
  8. 6.4.2 Global Remdesivir Sales Value by Region (2027-2032)
  9. 6.5 Global Remdesivir Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Remdesivir Sales Value (2021-2032)
  12. 6.6.2 North America Remdesivir Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Remdesivir Sales Value (2021-2032)
  15. 6.7.2 Europe Remdesivir Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Remdesivir Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Remdesivir Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Remdesivir Sales Value (2021-2032)
  21. 6.9.2 South America Remdesivir Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Remdesivir Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Remdesivir Sales Value Share by Country, 2025 VS 2032
7 Remdesivir Country-level Sales and Value Analysis
  1. 7.1 Global Remdesivir Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Remdesivir Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Remdesivir Sales by Country (2021-2032)
  4. 7.3.1 Global Remdesivir Sales by Country (2021-2026)
  5. 7.3.2 Global Remdesivir Sales by Country (2027-2032)
  6. 7.4 Global Remdesivir Sales Value by Country (2021-2032)
  7. 7.4.1 Global Remdesivir Sales Value by Country (2021-2026)
  8. 7.4.2 Global Remdesivir Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Remdesivir Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Remdesivir Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Remdesivir Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Remdesivir Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Remdesivir Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Remdesivir Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Remdesivir Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Remdesivir Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Remdesivir Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Remdesivir Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Remdesivir Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Remdesivir Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Remdesivir Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Remdesivir Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Remdesivir Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Remdesivir Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Remdesivir Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Remdesivir Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Remdesivir Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Remdesivir Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Remdesivir Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Remdesivir Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Remdesivir Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Remdesivir Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Remdesivir Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Remdesivir Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Remdesivir Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Remdesivir Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Remdesivir Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Remdesivir Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Remdesivir Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Remdesivir Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Remdesivir Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Remdesivir Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Remdesivir Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Remdesivir Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Remdesivir Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Remdesivir Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Remdesivir Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Remdesivir Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Remdesivir Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Remdesivir Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Remdesivir Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Remdesivir Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Remdesivir Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Remdesivir Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Remdesivir Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Remdesivir Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Remdesivir Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Remdesivir Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Remdesivir Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Remdesivir Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Remdesivir Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Remdesivir Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Remdesivir Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Remdesivir Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Remdesivir Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Remdesivir Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Remdesivir Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Remdesivir Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Remdesivir Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Remdesivir Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Remdesivir Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Remdesivir Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Remdesivir Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Remdesivir Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Remdesivir Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Remdesivir Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Remdesivir Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Remdesivir Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Remdesivir Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Remdesivir Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Remdesivir Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Remdesivir Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Remdesivir Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Remdesivir Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Remdesivir Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Remdesivir Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Remdesivir Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Remdesivir Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Remdesivir Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Remdesivir Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Remdesivir Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Remdesivir Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Kelun Pharma
  2. 8.1.1 Kelun Pharma Company Information
  3. 8.1.2 Kelun Pharma Business Overview
  4. 8.1.3 Kelun Pharma Remdesivir Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Kelun Pharma Remdesivir Product Portfolio
  6. 8.1.5 Kelun Pharma Recent Developments
  7. 8.2 Hunan Warrant Pharmaceutical
  8. 8.2.1 Hunan Warrant Pharmaceutical Company Information
  9. 8.2.2 Hunan Warrant Pharmaceutical Business Overview
  10. 8.2.3 Hunan Warrant Pharmaceutical Remdesivir Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hunan Warrant Pharmaceutical Remdesivir Product Portfolio
  12. 8.2.5 Hunan Warrant Pharmaceutical Recent Developments
  13. 8.3 Hainan Haiyao
  14. 8.3.1 Hainan Haiyao Company Information
  15. 8.3.2 Hainan Haiyao Business Overview
  16. 8.3.3 Hainan Haiyao Remdesivir Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hainan Haiyao Remdesivir Product Portfolio
  18. 8.3.5 Hainan Haiyao Recent Developments
  19. 8.4 Bright Gene
  20. 8.4.1 Bright Gene Company Information
  21. 8.4.2 Bright Gene Business Overview
  22. 8.4.3 Bright Gene Remdesivir Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bright Gene Remdesivir Product Portfolio
  24. 8.4.5 Bright Gene Recent Developments
  25. 8.5 Gilead Sciences
  26. 8.5.1 Gilead Sciences Company Information
  27. 8.5.2 Gilead Sciences Business Overview
  28. 8.5.3 Gilead Sciences Remdesivir Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Gilead Sciences Remdesivir Product Portfolio
  30. 8.5.5 Gilead Sciences Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Remdesivir Value Chain Analysis
  2. 9.1.1 Remdesivir Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Remdesivir Sales Mode & Process
  6. 9.2 Remdesivir Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Remdesivir Distributors
  9. 9.2.3 Remdesivir Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst